Search Results 411-420 of 17803 for testosterone
Testosterone treatment in multiple sclerosis: a pilot study. Sicotte NL. Nancy L; Giesser BS. Barbara S; Tandon V. Vinita; Klutch R. Ricki; Steiner B ...
* Participants must have a castrate level of serum/plasma testosterone (\< 50 ng/dL or \< 1.7 nmol/L) either by pharmaceutical or surgical methods. * ...
Find out about this condition that allows the testicle to move between the scrotum and groin.
Testosterone and prostate cancer: What's the connection? Transrectal biopsy of the prostate · Types of prostate cancer: Common and rare forms · What is prostate ...
Radiopharmaceuticals offer new hope. Prostate cancer cells rely on testosterone to help them grow. Hormone therapy, a treatment to stop your body from producing ...
Must have castration levels of testosterone (< 50 ng/dL) within 4 weeks prior to randomization. Must have progressive disease while receiving ADT as defined ...
Histologically or cytologically confirmed adenocarcinoma of the prostate · Ongoing androgen blockade demonstrated by serum testosterone concentration of less ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Prostate cancer: Does PSA level affect prognosis? SBRT for prostate cancer: How it compares to other treatments · Testosterone and prostate cancer: What's the ...
The purpose of this study is to retrospectively and prospectively compare maternal and fetal/newborn clinical outcomes in age-matched pregnant patients with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.